Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This trial is looking at pembrolizumab and chemotherapy for people with small cell lung cancer that has spread outside the lung (extensive stage).
It is for people who are going to have treatment for the first time.
Recruitment start: 14 July 2017
Recruitment end: 30 July 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Riyaz Shah
Merck Sharp & Dohme Ltd
Last reviewed: 20 August 2018
CRUK internal database number: 14851